Jim Cramer thinks sometimes stocks simply come down to supply and demand. When there is too much demand, a CEO can say anything and get away with financial murder. And when there isn't enough demand, nobody likes the CEO, no matter what is said.
That is exactly what Cramer sees occurring with Tesla, Apple and Fitbit.
Tesla CEO Elon Musk seems to think he can say whatever he wants and get away with it. Meanwhile, Apple CEO Tim Cook has to watch every word out of his mouth, even though he repeatedly delivers on his promises. And Fitbit CEO James Park seems to think guidance is for idiots, Cramer said.
"James Park should be banned from making any projections. His stock would be a heck of a lot higher if he were," Cramer said.
While many headlines touted that Fitbit had a shortfall, Cramer says that was wrong. The quarter was actually better than expected. The guidance however, was just as strange as the previous quarter, where Park slashed projections dramatically and then beat those numbers on Wednesday.
"I think these numbers mean nothing to him. I mean, he cut the guidance for next quarter but then boosted the full-year forecast. My advice: just make the product and shut up," Cramer said.
Read More Cramer: Elon Musk getting away with financial murder
With oil and the dollar pulling down stocks yet again on Thursday, Cramer fears the market could be in for a tough end to the week.
On Friday, the Labor Department is expected to release nonfarm payroll numbers. Cramer thinks it could be big enough to take focus away from oil and the dollar.
"If we get a weak payroll report, if this economy doesn't grow as robustly as we might have expected just a few weeks ago, then it will unleash a parade of horribles onto the stock market," the "Mad Money" host said.
The first negative repercussion Cramer expects is for oil to go down. That means investors will flee the market. He also expects to hear rumors about stagnant growth and the Fed's inability to do anything about it.
Cramer also anticipates both presumptive Republican nominee Donald Trump and Bernie Sanders to step up discussions on anemic job growth. At the same time, he thinks Trump could resurrect his attack on Apple for not making devices in the U.S.
Read More Cramer: Payroll numbers could 'unleash a parade of horribles' on the market
In honor of Cinco de Mayo this year, Cramer thought it would be the perfect time to re-rank beer companies, given that results from all of the industry's major players have now been reported.
"With Anheuser Busch InBev's gigantic $107 billion acquisition of SABMiller coming closer and closer to fruition, the competitive landscape in the beer business is about to change dramatically," the "Mad Money" host said.
Though Constellation Brands and Molson Coors have been his favorites lately, he decided to put all the big dogs to the test. He compared Constellation, Molson Coors, ABInBev and Boston Beer.
Ultimately, for those investors willing to pay roughly the same valuation for everything in the beer space, Cramer recommended sticking with Constellation Brands. He ranked Molson Coors in close second, given its MillerCoors acquisition.
Read More Cramer's Cinco de Mayo challenge: The king of beers
Zoetis is the world's largest animal health company that creates medicine and vaccines for both livestock and household pets. This category is widely considered to be one of the fastest growing in the drug business because customers are increasingly more willing to pay large sums of money to keep their pets healthy.
Zoetis reported a great quarter on Wednesday. It was also able to grow earnings at a fast pace because it cut costs aggressively, while management raised its full-year earnings guidance.
Unfortunately, the stock actually declined after the quarter. This was partially due to the fact that the stock had run so much into the quarter and investors took profits. It was also hurt by the recent rebound in the greenback, as well as what Cramer described as "simple, mindless ETF-driven selling" that had nothing to do with fundamentals.
Cramer spoke with Zoetis CEO Juan Ramon Alaix, who commented on the company's strength in China. "We have a very good presence in China, and this quarter we are launching a new product a vaccine for pigs, which is combining two different diseases," he said. "So, a great problem, and it is coming out of our team in China."
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
Walgreens Boots Alliance: "I'm kind of bummed. My charitable trust owns it, and then after the bell 15 million shares were filed by a selling shareholder. Not what you want to see. The stock is going to get hit on that."
Enterprise Products Partners: "Here's the problem with Enterprise: It's in a really bad group, but it is of the bad group along with Magellan Petroleum. Those stocks are making a comeback, but I am not anxious to put more people in it."